ZimVie (ZimVie) Asset Impairment Charge

: $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

ZimVie's Asset Impairment Charge for the three months ended in Dec. 2023 was $0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

ZimVie Asset Impairment Charge Historical Data

The historical data trend for ZimVie's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

142.00

ZimVie Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge												-	-	-	-	-

ZimVie Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

ZimVie Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of ZimVie's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

ZimVie (ZimVie) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

O23:Germany

Address

10225 Westmoor Drive, Westminster, CO, USA, 80021

Website

https://www.zimvie.com

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Executives

Camber Capital Management Lp	10 percent owner	101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali	director, officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc.	10 percent owner	345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz	director	MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar	director	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec	director	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider	officer: Chief Accounting Officer	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021